[PCRX] YoY Quarter Result on 30-Sep-2016 [#Q3]

Stock
[PCRX] Pacira BioSciences, Inc.
Announcement Date
02-Nov-2016
Financial Year
2016
Quarter
30-Sep-2016 [#Q3]
Profit Trend
QoQ- -178.51%
YoY- -818.21%
Quarter Report
PCRX's Result
PCRX's Financial Summary
View:
Show?
Quarter Result
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
Revenue 104,685 83,448 67,335 68,355 62,213 52,048 23,259 28.47%
PBT -5,816 -702 -7,552 -22,128 3,367 -3,004 -14,784 -14.39%
Tax 271 -62 45 36 281 1,994 1,884 -27.60%
NP -6,087 -640 -7,597 -22,164 3,086 -3,004 -14,784 -13.74%
Tax Rate - - - - -8.35% - - -
Total Cost 110,772 84,088 74,932 90,519 59,127 55,052 38,043 19.48%
Ratio Analysis
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
NP Margin -5.81 -0.77 -11.28 -32.42 4.96 -5.77 -63.56 -32.87%
Per Share
30/09/19 30/09/18 30/09/17 30/09/16 30/09/15 30/09/14 30/09/13 CAGR
EPS -0.15 -0.02 -0.19 -0.59 0.08 -0.08 -0.44 -16.41%
EPS Diluted -0.15 -0.02 -0.19 -0.59 0.08 -0.08 -0.44 -16.41%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.